| Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes. SR Ferdosi, R Ewaisha, F Moghadam, S Krishna, JG Park, ... Nature communications 10 (1), 1842-1842, 2019 | 182 | 2019 |
| Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation R Ewaisha, KS Anderson Frontiers in Bioengineering and Biotechnology 11, 1138596, 2023 | 25 | 2023 |
| Serum immune profiling for early detection of cervical disease R Ewaisha, G Panicker, P Maranian, ER Unger, KS Anderson Theranostics 7 (16), 3814, 2017 | 25 | 2017 |
| Serum Immune Profiling for Early Detection of Cervical Disease R Ewaisha, G Panicker, P Maranian, ER Unger, KS Anderson Theranostics 7 (16), 3814, 2017 | 25 | 2017 |
| Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model SF Mossallam, EI Amer, RE Ewaisha, AM Khalil, HM Aboushleib, ... BMC infectious diseases 15, 1-16, 2015 | 24 | 2015 |
| Programmable protein arrays for immunoprofiling HPV‐associated cancers R Ewaisha, I Meshay, J Resnik, BA Katchman, KS Anderson Proteomics 16 (8), 1215-1224, 2016 | 21 | 2016 |
| Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection RE Ewaisha, M Bahey-El-Din, SF Mossallam, EI Amer, HM Aboushleib, ... Experimental parasitology 145, 51-60, 2014 | 21 | 2014 |
| Vaccine design S Thomas Springer New York, 2016 | 17 | 2016 |
| Crucial considerations for pipelines to validate circulating biomarkers for breast cancer R Ewaisha, CD Gawryletz, KS Anderson Expert review of proteomics 13 (2), 201-211, 2016 | 9 | 2016 |
| Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds NE Larkey, R Ewaisha, MA Lasho, MM Roforth, D Granger, CR Jerde, ... Microbiology Spectrum 10 (4), e01154-22, 2022 | 8 | 2022 |
| Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes. Nat Commun. 2019; 10 (1): 1842 SR Ferdosi, R Ewaisha, F Moghadam, S Krishna, JG Park, ... | 5 | |
| Modulating human Cas9-specific host immune response R Ewaisha, S Kiani, SR Ferdosi, K Anderson, F Moghadam, S Krishna, ... US Patent 11,208,640, 2021 | 3 | 2021 |
| Proteomic monitoring of B cell immunity R Ewaisha, KS Anderson Vaccine Design: Methods and Protocols: Volume 1: Vaccines for Human Diseases …, 2016 | 2 | 2016 |
| Successful detection, expression and purification of the alternatively spliced truncated Sm14 antigen of an Egyptian strain of Schistosoma mansoni RE Ewaisha, M Bahey-El-Din, SF Mossallam, AM Khalil, HM Aboushleib Journal of helminthology 89 (6), 764-768, 2015 | 2 | 2015 |
| Low-cost, disposable fluorescence-based biorecognition system architecture for multiplexed point-of-care molecular diagnostics JT Smith, U Obahiagbon, R Ewaisha, BA Katchman, K Kaftanoglu, ... 2016 IEEE Healthcare Innovation Point-Of-Care Technologies Conference (HI …, 2016 | 1 | 2016 |
| Modulating Human Cas9-Specific Host Immune Response S Kiani, R Ewaisha, SR Ferdosi, K Anderson, F Moghadam, S Krishna, ... US Patent App. 17/546,810, 2022 | | 2022 |
| Heavy Chain Disease Reviewed on MALDI-TOF R Ewaisha, A Dispenzieri, M Willrich, M Kohlhagen, D Murray AMERICAN JOURNAL OF CLINICAL PATHOLOGY 156, S11-S11, 2021 | | 2021 |
| Circulating Biomarkers for Cancer Immunoprofiling RMEM Ewaisha Arizona State University, 2018 | | 2018 |
| Future Strategies for Managing Congestion in Heart Failure Patients Using Cardiac Biomarker-Guided Self-Testing JT Smith, U Obahiagbon, R Ewaisha, M Zhu, MFA McFadden, ... Journal of Clinical and Experimental Cardiology 8 (10), 2017 | | 2017 |
| Detection of circulating immune biomarkers of cervical disease using proteome arrays R Ewaisha, I Meshay, J Resnik, T Bharaj, KS Anderson Cancer Research 77 (13_Supplement), 2217-2217, 2017 | | 2017 |
Karen S. AndersonArizona State University在 asu.edu 的电子邮件经过验证
